Aurinia Pharmaceuticals (AUPH) Earnings
|
Expand Research on AUPH
| Next EPS Date | 7/30/26 | EPS Growth Rate | +43.8% |
|---|---|---|---|
| Average EPS % Beat Rate | +252.4% | Revenue Growth Rate | +15.1% |
| Average % Move 1-Wk after EPS | +11.1% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
7/30/26  |
Q226 | N/A | $0.23 | N/A | N/A | $80.56M | = | N/A | N/A | ||
| 5/7/26 | Q126 | $0.25 | $0.19 | +$0.06 | $77.7M | $75.29M | = |  | | Details | |
| 5/5/26 |
Q126 | N/A | $0.19 | N/A | N/A | $75.29M | = | N/A | N/A | ||
| 5/4/26 |
Q126 | N/A | $0.19 | N/A | N/A | $75.29M | = | N/A | N/A | ||
| 5/1/26 |
Q126 | N/A | $0.19 | N/A | N/A | $75.29M | = | N/A | N/A | ||
| 4/30/26 |
Q126 | N/A | $0.19 | N/A | N/A | $75.29M | = | N/A | N/A | ||
| 2/26/26 | Q425 | $1.53 | $0.15 | +$1.38 | $77.1M | $74.41M | = | | | Details | |
| 11/4/25 | Q325 | $0.23 | $0.16 | +$0.07 | $73.47M | $67.7M | = | | | Details |
